| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/12/2004 | WO2004067701A2 Improved genetic elements providing high levels of expression |
| 08/12/2004 | WO2004067698A2 Helminth-derived antigens having capacity of providing protection against parasites |
| 08/12/2004 | WO2004067571A1 Monoclonal antibody against human hepatoma and use thereof |
| 08/12/2004 | WO2004067568A2 Human il-1 beta antagonists |
| 08/12/2004 | WO2004067567A2 Anti-dengue virus antibodies, compositions, methods and uses |
| 08/12/2004 | WO2004067565A1 Genetically-modified yeasts which can float in a liquid medium, production method thereof and use of same |
| 08/12/2004 | WO2004067563A1 Peptide inhibitors of toxins derived from ll-37 |
| 08/12/2004 | WO2004067560A2 Herpes simplex vp16 protein binding polypeptides |
| 08/12/2004 | WO2004067558A1 Means for regulating the expression of human isoforms of ant |
| 08/12/2004 | WO2004067554A2 Compositions and methods of tolerizing a primate to an antigen |
| 08/12/2004 | WO2004067549A2 Peptides directed against antibodies, which cause cold-intolerance, and the use thereof |
| 08/12/2004 | WO2004067029A1 Method of preparing a vaccine and anti-tumor vaccines |
| 08/12/2004 | WO2004066989A1 Down-regulation of target-gene with pei/single-stranded oligoribonucleotide comp lexes |
| 08/12/2004 | WO2004066949A2 Antisense oligonucleotides that inhibit expression of hif-1 |
| 08/12/2004 | WO2004066947A2 Hyperthermia oncolysis co-therapy |
| 08/12/2004 | WO2004066933A2 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 08/12/2004 | WO2004066914A2 Variant integrin polypeptides and uses thereof |
| 08/12/2004 | WO2004066909A2 Method for identifying novel treatments of inflammatory disease in the gut |
| 08/12/2004 | WO2004066724A1 Transgenic animal having fatty acid desaturase and method of producing the same |
| 08/12/2004 | WO2004056994A3 Quasirandom structure and function guided synthesis methods |
| 08/12/2004 | WO2004056969A3 Generation of plants with altered oil content |
| 08/12/2004 | WO2004056967A3 Generation of plants with altered oil content |
| 08/12/2004 | WO2004056858A3 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders |
| 08/12/2004 | WO2004054969A3 Sacromastigophoric therapeutic agent delivery system |
| 08/12/2004 | WO2004053137A3 Method for protein production |
| 08/12/2004 | WO2004050859A3 Homologous recombination in multipotent adult progenitor cells |
| 08/12/2004 | WO2004050854A3 Methods for identifying the activity of gene products |
| 08/12/2004 | WO2004050680A3 Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses |
| 08/12/2004 | WO2004048582A3 Recombinant poxvirus comprising at least two cowpox ati promoters |
| 08/12/2004 | WO2004046360A3 Method of controlling cellular processes in plants |
| 08/12/2004 | WO2004046305A3 Method and system for cell and/or nucleic acid molecules isolation |
| 08/12/2004 | WO2004045530A3 Methods for treating, preventing, or reducing cardiac disorders using fadd inhibitors |
| 08/12/2004 | WO2004043145A3 Auxin-repressed, dormancy-associated promoter and uses thereof |
| 08/12/2004 | WO2004042015A3 Methods and vectors for controlling gene expression |
| 08/12/2004 | WO2004041867A3 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 08/12/2004 | WO2004037998A3 Natural promoters for gene expression in c1 metabolizing bacteria |
| 08/12/2004 | WO2004033639A3 Targeting of herpes simplex virus to specific receptors |
| 08/12/2004 | WO2004032860A3 Hiv vaccine formulations |
| 08/12/2004 | WO2004027062A3 Functional correction of the -786c/t variance of the human enos gene |
| 08/12/2004 | WO2004020623A3 Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers |
| 08/12/2004 | WO2004020604A3 Allele specific primer extension |
| 08/12/2004 | WO2004020585A3 Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry |
| 08/12/2004 | WO2004018676A3 Rnai probes targeting cancer-related proteins |
| 08/12/2004 | WO2004018673A3 Isolation and cloning of dna from uncultivated organisms |
| 08/12/2004 | WO2004015071A3 CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 08/12/2004 | WO2004013304A3 Sugar and lipid metabolism regulators in plants iv |
| 08/12/2004 | WO2004013299A3 Methods for the production of cells and mammals with desired genetic modifications |
| 08/12/2004 | WO2004011611A3 Taci antibodies and uses thereof |
| 08/12/2004 | WO2004011594A3 Novel method for analyzing nucleic acid and use thereof for evaluating the degree of mrna editing of the serotonin 5-ht2c receptor |
| 08/12/2004 | WO2004009024A3 Modulation of protein kinase c-iota expression |
| 08/12/2004 | WO2004007678A3 Codon optimized synthetic plasmids |
| 08/12/2004 | WO2004007531A3 Activated checkpoint therapy and methods of use thereof |
| 08/12/2004 | WO2004003512A3 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 08/12/2004 | WO2004001000A3 Intron double stranded rna constructs and uses thereof |
| 08/12/2004 | WO2003102145A3 Glioma-specific transcription control nucleic acids |
| 08/12/2004 | WO2003091406A3 Amplification of dna to produce single-stranded product of defined sequence and length |
| 08/12/2004 | WO2003079977A3 Novel compositions and methods in cancer associated with altered expression of mcm3ap |
| 08/12/2004 | WO2003078590A3 Early inflorescence-preferred regulatory elements and uses thereof |
| 08/12/2004 | WO2003066804A3 Thermus scotoductus nucleic acid polymerases |
| 08/12/2004 | WO2003066802A3 Gene expression analysis using nicking agents |
| 08/12/2004 | WO2003054217A3 Plant msh2 sequences and methods of use |
| 08/12/2004 | WO2003052111A9 Cotton alpha-globulin promoter for seed-specific expression of transgenes |
| 08/12/2004 | WO2003051182A3 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia |
| 08/12/2004 | WO2003048337A3 Antibody to latent membrane proteins and uses thereof |
| 08/12/2004 | WO2003042693A3 Method for measuring intracellular atp and/or gene expression |
| 08/12/2004 | WO2003039484A3 Novel compositions and methods for cancer |
| 08/12/2004 | WO2003037060A3 Compositions and methods for wt1 specific immunotherapy |
| 08/12/2004 | WO2003032913A3 Methods and compositions for targeting proteins across the blood brain barrier |
| 08/12/2004 | WO2003029293A3 Modulators of notch ic protease activity for use in immunotherapy |
| 08/12/2004 | WO2003023028A9 Fungal glyoxal oxidases |
| 08/12/2004 | WO2003012032A3 Antisense modulation of p70 s6 kinase expression |
| 08/12/2004 | WO2002090504A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 08/12/2004 | WO2002086147A3 Single nucleotide polymorphisms diagnostic for schizophrenia |
| 08/12/2004 | WO2002077179A8 Leinamycin biosynthesis gene cluster and its components and their uses |
| 08/12/2004 | WO2002059299A9 Expression cloning method |
| 08/12/2004 | WO2002057408A3 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same |
| 08/12/2004 | WO2001068807A3 Identification of in vivo dna binding loci of chromatin proteins using a tethered nucleotide modification enzyme |
| 08/12/2004 | US20040158893 Transgenic plants comprising nucleotide sequences coding kinesin products for increasing germ cell ploidy; hybrid crop plants |
| 08/12/2004 | US20040158892 Comprises anther specific regulatory sequences for use as control agents for expression of heterologous nucleotide sequences in plants; disease resistant plants |
| 08/12/2004 | US20040158891 Comprises nucleotide sequences coding senescence induced hydrolase in antisense orientation for generating plants with prolonged life or shelf life, flowering, reduced fruit spoilage, seed aging and/or reduced yellowing of leaves |
| 08/12/2004 | US20040158890 Sequences encoding PhzO and methods |
| 08/12/2004 | US20040158889 Efficient system for RNA silencing |
| 08/12/2004 | US20040158888 Nucleic acids coding retoviral regulatory sequences for use as tools in generation of transgenic seeds for propagatgion of disease, heat, herbicide and drought resistant plants |
| 08/12/2004 | US20040158887 Use of regulatory sequences in transgenic plants |
| 08/12/2004 | US20040158886 Generating, in vivo, random genetic mutation in polypeptide by blocking endogenous mismatch repair; high throughput assay for genetic vaccines |
| 08/12/2004 | US20040158885 Chronic hepatitis virus infection and clonal hepatocellular carcinoma in mouse repopulated livers |
| 08/12/2004 | US20040158884 Transgenic mouse having conditional knock-out of myostatin function |
| 08/12/2004 | US20040158882 Novel vectors in avian transgenesis |
| 08/12/2004 | US20040158881 Animal selected for lacking heparan sulfate 3-0-sulfotransferase-1 and uses thereof |
| 08/12/2004 | US20040158880 Suppression of endogenous immunoglobulin expression in transgenic non-human animals expressing humanized or human antibodies |
| 08/12/2004 | US20040158053 Plasmid comprising nucleotide sequences coding antigenic proteins for use in prevention and treatment of infectious and neoplastic diseases; gene therapy |
| 08/12/2004 | US20040158052 Nucleotide sequences coding soybean seed specific lipocortin regulatory sequences for use as tool in controlling expression of heterologous gene sequences in plants |
| 08/12/2004 | US20040158045 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders |
| 08/12/2004 | US20040158044 Comprises polypeptide which binds major histocompatibility complex for use in cancer diagnosis and treatment; antitumor agents |
| 08/12/2004 | US20040158040 Peptides participating in prionization of heterogenous erf3 |
| 08/12/2004 | US20040157788 production of antibodies containing K light chains, in order to provide high affinity reproducibly |
| 08/12/2004 | US20040157775 Effector proteins of rapamycin |
| 08/12/2004 | US20040157332 Using prokaryotic recombinase to initiate site specific insertion/deletion of extrachromosomal segments of DNA into eukaryotic genomes; gene therapy |
| 08/12/2004 | US20040157331 Controlling, activating gene operon promoter, induced by aromatic carboxylic acids in bacteria host cell, for industrial scale biosynthesis, expression a heterologous nucleic acid, encoded protein for enzymatic biosynthetic pathway |
| 08/12/2004 | US20040157330 Compositions and methods for targeted biological delivery of molecular carriers |